Zacks Investment Research downgraded shares of BALCHEM CP CL-B (BCPC) from NEUTRAL to UNDERPERFORM on June 15, 2012, with a target price of $29.50.
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients for the food, feed and medical sterilization industries. They operate in two business segments, the micro-encapsulation of performance ingredients and the repackaging and marketing of high quality specialty gases. They sell their products through their own sales force, independent distributors and sales agents.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on BALCHEM CP CL-B (BCPC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment